Deerfield Management Company, L.P. (Series C) Organogenesis Holdings Inc. Transaction History

Deerfield Management Company, L.P. (Series C)

$5.38 Billion
Q3 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$4.74 - $8.15 $19 Million - $32.7 Million	-4,009,136 Reduced 47.41%	4,447,740 $21.7 Million
Q4 2021 Feb 14, 2022	BUY	$9.02 - $13.5 $8.97 Million - $13.4 Million	994,333 Added 13.32%	8,456,876 $78.1 Million
Q3 2021 Nov 15, 2021	BUY	$13.71 - $17.18 $3.3 Million - $4.13 Million	240,416 Added 3.33%	7,462,543 $106 Million
Q2 2021 Aug 16, 2021	BUY	$14.92 - $23.23 $63.1 Million - $98.2 Million	4,226,489 Added 141.09%	7,222,127 $120 Million
Q1 2021 May 17, 2021	BUY	$7.33 - $21.06 $22 Million - $63.1 Million	2,995,638 New	2,995,638 $54.6 Million

Others Institutions Holding ORGO

# of Institutions

117

Shares Held

63.2M

Call Options Held

25K

Put Options Held

23.2K

Morgan Stanley New York, NY

12M
Shares

$46.2 Million
0.0% of portfolio
Soleus Capital Management, L.P. Greenwich, CT

11.8M
Shares

$45.7 Million
2.88% of portfolio
Black Rock Inc. New York, NY

5.09M
Shares

$19.6 Million
0.0% of portfolio
Deutsche Bank Ag\ Frankfurt Am Main, 2M

4.84M
Shares

$18.7 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

3.67M
Shares

$14.2 Million
0.0% of portfolio

View Full List

About Organogenesis Holdings Inc.

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $505M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

More about ORGO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Account